ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MACK Merrimack Pharmaceuticals Inc

15.03
0.05 (0.33%)
May 02 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000139k00
Operating Income -473k-577k-486k-504k-607k-447k-569k-531k
Pre Tax Income -472k-132k-478k-442k-489k-271k-391k-279k
Net Income -475k-132k-478k-442k-492k-271k-391k-279k
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -473k-132k-486k-504k-607k-447k-430k-531k
EBITDA -473k-577k-486k-504k-607k-447k-569k-531k
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 144.27M0000000
Operating Income -110.14M-95.77M-65.58M-27.27M-5.01M-2.62M-2.17M-2.18M
Pre Tax Income -153.52M-118.4M-68.46M-22.74M-3.01M-2.45M-1.54M-1.17M
Net Income -151.74M472.03M-40.51M-17.33M-3.03M-2.46M-1.54M-1.18M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.16535.376-3.036-1.295-0.226-0.183-0.109-0.082
EBIT -110.15M-84.65M-65.58M-21.99M-3.06M-2.47M-1.73M-2.04M
EBITDA -99.44M-90.55M-61.5M-25.04M-5.01M-2.62M-2.17M-2.18M

Your Recent History

Delayed Upgrade Clock